2020 FDA/EMA approvals for new immunotherapy drug technologies and applications
Immunotherapy is a new approach applied in treatment of infections, autoimmune diseases, or cancer by activating or suppressing the immune system. Pre-clinical and clinical investigations on discovering new products with high efficacy and low side effects are still ongoing. Clinical studies revealed...
Saved in:
Main Authors: | Maryam Monajati (Author), Samira Sadat Abolmaali (Author), Alimohammad Tamaddon (Author) |
---|---|
Format: | Book |
Published: |
Shiraz University of Medical Sciences,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging technology trends in regulatory approvals of cancer immunotherapy drugs by the FDA and EMA
by: Maryam Monajati, et al.
Published: (2024) -
The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
by: Ioana Gherghescu, et al.
Published: (2020) -
Lutathera<sup>®</sup>: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
by: Ute Hennrich, et al.
Published: (2019) -
FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024) -
FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024)